Dipeptidyl‐Peptidase‐4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low‐Density Lipoprotein (LDL) Receptor‐Deficient Mice

BACKGROUND: The results of recent studies suggest that dipeptidyl‐peptidase‐4 inhibitors have antiatherogenic effects. However, whether or not dipeptidyl‐peptidase‐4 inhibitors could suppress arterial inflammation and intimal hyperplasia after injury remains undetermined. The present study aims to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Akita, Koji, Isoda, Kikuo, Shimada, Kazunori, Daida, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392431/
https://www.ncbi.nlm.nih.gov/pubmed/25770025
http://dx.doi.org/10.1161/JAHA.114.001469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392431/
https://www.ncbi.nlm.nih.gov/pubmed/25770025
http://dx.doi.org/10.1161/JAHA.114.001469

Ejemplares similares